Press release
Global Enasidenib Market, Size, Share, Analysis Report & Forecast to 2026
The Enasidenib Market is expected to register at a highest CAGR during the forecast period. Enasidenib is a drug that targets a gene mutation called IDH2 that affects the bone marrow. A mutation in the IDH2 gene inhibits young blood cells from maturing into healthy adult blood cells, resulting in acute myeloid leukaemia symptoms. AML is a form of blood cancer, that starts in the bone marrow and spreads throughout the body. The illness spreads quickly to other sections of the body.Free Sample Copy @ https://www.omrglobal.com/request-sample/enasidenib-market
Since the COVID-19 virus outbreak in December 2019, the disease spread to almost every country around the globe with the World Health Organization, declaring it a public health emergency. The global impacts of the coronavirus disease (COVID-19) had significantly affect the Enasidenib market in 2020.
Enasidenib is a drug that is used to treat adults with acute myeloid leukaemia (AML), who has an IDH2 mutation. When AML has affected again or has not improved after previous treatment, this medication is given.
A Full Report of Global Enasidenib Market is Available at:
https://www.omrglobal.com/industry-reports/enasidenib-market
The revenue share of the Enasidenib market will increase as the healthcare industry develops. The market will expand as people are becoming more aware of health issues, and better facilities are beingavailable. As a result, the market in developed regions will grow dramatically.
Symptoms of Enasidenib syndrome include fever, cough, trouble breathing, bone pain, rapid weight gain, or swelling in your arms, legs, underarms, groin, or neck.
In August 2017, Enasidenibis was approved by the U.S. Food and Drug Administration (FDA) for the treatment of geriatric patients with relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 mutation as detected by an FDA-approved test .and IDHIFA wasalso approved in Australia and Canada in August 2017.
Global Enasidenib Market – Segmentation
By Type:
50mg
100mg
By Application:
Hospital
Pharmacy
Global Enasidenib Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Celgene Corporation
Agios Pharmaceuticals
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/enasidenib-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Enasidenib Market, Size, Share, Analysis Report & Forecast to 2026 here
News-ID: 2418957 • Views: …
More Releases from Orion Market Research
Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033.
Road Marking Paint Market Overview
The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new…
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period.
Outboard Boat Market Overview
The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including…
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033.
Mobile Ticketing Market Overview
The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,…
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033.
Metal Alloy Market Overview
The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in…
More Releases for Enasidenib
Enasidenib Market Development, Industry Trends, Demand and Growth Analysis and F …
The global Enasidenib market was valued at approximately USD 78 million in 2023 and is projected to reach USD 125.9 million by 2030, reflecting a compound annual growth rate (CAGR) of 7.1% from 2024 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/enasidenib-market
Enasidenib Market Overview:
The Enasidenib market is primarily driven by the increasing prevalence of acute myeloid leukemia (AML), specifically in patients with an IDH2 mutation. Enasidenib, a targeted…
Global Enasidenib Market Estimated to Experience a Hike in Growth by 2031
The global Enasidenib market was valued at approximately USD 87.9 million in 2023 and is projected to reach around USD 151.8 million by 2031, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.
Global Enasidenib Market Overview
The global enasidenib market is experiencing steady growth, driven by its effectiveness in treating relapsed or refractory acute myeloid leukemia (AML) with IDH2 mutations. In 2023, the market…
Enasidenib Market Analysis, Size, Current Scenario and Future Prospects
The Enasidenib Market is expected to register at a highest CAGR during the forecast period. Enasidenib is a drug that targets a gene mutation called IDH2 that affects the bone marrow. A mutation in the IDH2 gene inhibits young blood cells from maturing into healthy adult blood cells, resulting in acute myeloid leukaemia symptoms. Enasidenib Market research report allows making important decision making essential for business growth. It helps key…
2022 Enasidenib Market Report- by Key Segments, Growth Size, Emerging Trends and …
Enasidenib Market report incorporates item types, market applications, geographic areas, and financial backers and providers. The overall statistical surveying gives a complete investigation of the business for the figure time frame. In addition, the examination incorporates a few divisions just as a full investigation of the market's patterns and critical determinants. Moreover, Enasidenib Market report assists you in overcoming the difficulties by applying various strategies.
Download FREE PDF of the Report…
Global Enasidenib Drugs Market Report 2018-2025 | Segmantation by Industry Surve …
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
In 2018, the global Enasidenib Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the…
Global Enasidenib Market Report 2018: Top Manufacturers, Regions, Type and Appli …
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
In 2018, the global Enasidenib market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base…
